Search results
Results from the WOW.Com Content Network
[8] [9] In 1999, the hospital was sold to Tulsa-based Hillcrest Medical Center, a locally owned non-profit organization, which already owned another hospital in Tulsa. [7] In 2004, the for-profit Ardent Health Services, also of Nashville, bought the Hillcrest system. [7]
CityPlex Towers, originally known as City of Faith Medical and Research in Tulsa, Oklahoma There are three triangular towers with over 2,200,000 square feet (200,000 m 2 ) of office space. [2] The tallest is the 60-story CityPlex Tower which at 648 feet (198 m) is the third tallest building in Oklahoma (after Devon Tower and BOK Tower ).
Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous system. It is an extremely rare condition, affecting as few as 1 in 10,000,000 people per year.
As of November 2, 2006, Tulsa Regional Medical Center was rechristened as the Oklahoma State University Medical Center, as per the terms of the 50-year agreement. Oklahoma legislators appropriated $40 million in funding towards improving the hospital's technology and facilities.
MEAK is a form of progressive myoclonus epilepsy that typically begins between the ages of 3 and 15 years (the average of onset is 10 years). The first symptoms may include ataxia and myoclonus (unsteadiness and difficulty coordinating movements), along with generalized tonic-clonic ("grand mal") seizures.
Myoclonus is a brief, involuntary, irregular (lacking rhythm) twitching of a muscle, a joint, or a group of muscles, different from clonus, which is rhythmic or regular.
Myoclonus is usually classified physiologically to optimize treatment. Myoclonus is a precursor effect to myoclonus dystonia and most commonly begins in childhood or adolescence. [4] [5] Myoclonus is classified as cortical, subcortical, peripheral or spinal. Cortical myoclonus is the most common of these four and affects the upper limbs and face.
Familial adult myoclonus Epilepsy (FAME) This is a condition characterized by the repetition of non-coding sequences and has been identified using various abbreviations. Initially, it was associated with four primary gene locations: FAME1 (8q23.3–q24.1), FAME2 (2p11.1–q12.1), FAME3 (5p15.31–p15.1), and FAME4 (3q26.32–3q28).